Over the last several years, neuronal stabilizing agents (also known as anti-convulsants or epilepsy medications) have been increasingly prescribed for Migraine prevention. Out of the four medications that are actually FDA approved for Migraine prevention, two of them -- Depakote and Topamax -- are neuronal stabilizing agents. It has been thought that these medications are effective for Migraine prevention because they calm overactive neurons in the brains of Migraineurs.

Trileptal (oxcarbazepine) is one medication in this family that has been prescribed off-label for Migraine prevention. A new study has now shown that Trileptal apparently does not work well as a Migraine preventive. The results of this research are published in the February 12, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology...

Continue reading Trileptal Fails Test for Migraine Prevention.